Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model (Q39215780)

10 September 2017

title

Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor model (English)

1 reference

10 September 2017

1 reference

1 reference

Wenjia Lou

1

1 reference

10 September 2017

Qing Chen

2

1 reference

10 September 2017

Leina Ma

3

1 reference

10 September 2017

Jia Liu

4

1 reference

10 September 2017

Zhi Yang

5

1 reference

10 September 2017

Junjie Shen

6

1 reference

10 September 2017

Youhong Cui

7

1 reference

10 September 2017

Xiu-Wu Bian

8

1 reference

10 September 2017

Cheng Qian

9

1 reference

10 September 2017

publication date

6 January 2013

1 reference

Journal of Molecular Medicine

10 September 2017

published in

1 reference

10 September 2017

volume

91

1 reference

10 September 2017

issue

6

1 reference

10 September 2017

page(s)

715-725

1 reference

A MicroRNA targeting dicer for metastasis control

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

MicroRNAs and Metastasis: Little RNAs Go a Long Way

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

microRNAs join the p53 network--another piece in the tumour-suppression puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

miR-34a repression of SIRT1 regulates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

Therapy of cancer by cytokines mediated by gene therapy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

Expression of miR-122 mediated by adenoviral vector induces apoptosis and cell cycle arrest of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

Treatment of cancer with a novel dual-targeted conditionally replicative adenovirus armed with mda-7/IL-24 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

Melanoma differentiation associated gene-7 (mda-7)/IL-24: a 'magic bullet' for cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

A simplified system for generating recombinant adenoviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

Potent antitumor activity in experimental hepatocellular carcinoma by adenovirus-mediated coexpression of TRAIL and shRNA against COX-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-012-0985-X

miR-34a as part of the resistance network in chronic lymphocytic leukemia

21 January 2018

1 reference

12 December 2020

Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma

1 reference

12 December 2020

MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.

1 reference

12 December 2020

MicroRNA-151 and its hosting geneFAK(focal adhesion kinase) regulate tumor cell migration and spreading of hepatocellular carcinoma

1 reference

12 December 2020

10.1007/S00109-012-0985-X

Identifiers

DOI

1 reference

10 September 2017

1 reference